Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MURA Mural Oncology

盘前交易 05-06 07:51:48 EDT

2.54

-0.10

-3.79%

盘前2.52

-0.02-0.79%

07:41 EDT

最高2.62	最低2.52	成交量36.68万
今开2.61	昨收2.64	日振幅3.79%
总市值4,376万	流通市值3,003万	总股本1,723万
成交额94.00万	换手率3.10%	流通股本1,182万
市净率0.31	ROE-63.57%	每股收益-7.58
52周最高4.74	52周最低0.9500	市盈率-0.34
股息0.00	股息收益率0.00	ROA-36.68%

北京优虎网络科技有限公司

{"stockData":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.54,"timestamp":1746475200000,"preClose":2.64,"halted":0,"volume":366785,"hourTrading":{"tag":"盘前","latestPrice":2.52,"preClose":2.54,"latestTime":"07:41 EDT","volume":23,"amount":57.96,"timestamp":1746531704708},"delay":0,"floatShares":11823307,"shares":17228291,"eps":-7.5799,"marketStatus":"盘前交易","change":-0.1,"latestTime":"05-06 07:51:46 EDT","open":2.61,"high":2.62,"low":2.52,"amount":940027.041155,"amplitude":0.037879,"askPrice":2.82,"askSize":100,"bidPrice":2.52,"bidSize":477,"shortable":3,"etf":0,"ttmEps":-7.5799,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746538200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.54,"preHourTrading":{"tag":"盘前","latestPrice":2.52,"preClose":2.54,"latestTime":"07:41 EDT","volume":23,"amount":57.96,"timestamp":1746531704708},"postHourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.54,"latestTime":"18:45 EDT","volume":1103,"amount":2773.105,"timestamp":1746485124259},"volumeRatio":0.9375003192117211,"impliedVol":0.7125,"impliedVolPercentile":0.3416},"requestUrl":"/m/hq/s/MURA/tweets","defaultTab":"tweets","newsList":[{"id":"2532015804","title":"Mural Oncology Plc5月2日成交额为93.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532015804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532015804?lang=zh_cn&edition=full","pubTime":"2025-05-03 10:08","pubTimestamp":1746238084,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，Mural Oncology Plc成交额为93.40万美元，成交额较昨日减少7.82%，当日成交量为35.64万股。Mural Oncology Plc于2025年5月2日涨1.15%，报2.64美元，该股过去5个交易日涨1.54%，年初至今跌18.01%，过去60日跌35.14%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|93.40万|-7.82%|35.64万|#|2025-05-01|101.32万|9.55%|38.98万|#|2025-04-30|92.49万|-12.24%|35.17万|#|2025-04-29|105.38万|-11.41%|40.34万|#|2025-04-28|118.95万|4.91%|45.50万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2532010192","title":"Mural Oncology Plc4月30日成交额为92.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532010192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532010192?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:08","pubTimestamp":1746065315,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Mural Oncology Plc成交额为92.49万美元，成交额较昨日减少12.24%，当日成交量为35.17万股。Mural Oncology Plc于2025年4月30日涨0.38%，报2.63美元，该股过去5个交易日跌5.05%，年初至今跌18.32%，过去60日跌28.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2531728073","title":"Mural Oncology Plc4月29日成交额为105.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531728073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531728073?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:07","pubTimestamp":1745978824,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Mural Oncology Plc成交额为105.38万美元，成交额较昨日减少11.41%，当日成交量为40.34万股。Mural Oncology Plc于2025年4月29日涨0.38%，报2.62美元，该股过去5个交易日跌3.68%，年初至今跌18.63%，过去60日跌30.13%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2531921286","title":"Mural Oncology Plc4月28日成交额为118.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531921286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531921286?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:06","pubTimestamp":1745892370,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Mural Oncology Plc成交额为118.95万美元，成交额较昨日增加4.91%，当日成交量为45.50万股。Mural Oncology Plc于2025年4月28日涨0.38%，报2.61美元，该股过去5个交易日跌2.97%，年初至今跌18.94%，过去60日跌30.77%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2530111313","title":"Mural Oncology Plc4月25日成交额为113.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530111313","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530111313?lang=zh_cn&edition=full","pubTime":"2025-04-26 10:05","pubTimestamp":1745633136,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，Mural Oncology Plc成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2529059087","title":"Mural Oncology Plc4月22日成交额为321.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529059087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529059087?lang=zh_cn&edition=full","pubTime":"2025-04-23 10:04","pubTimestamp":1745373850,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，Mural Oncology Plc成交额为321.75万美元，成交额较昨日减少11.96%，当日成交量为118.25万股。Mural Oncology Plc于2025年4月22日涨1.12%，报2.72美元，该股过去5个交易日涨164.08%，年初至今跌15.53%，过去60日跌31.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2529838213","title":"Mural Oncology Plc盘中异动 股价大跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529838213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529838213?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:57","pubTimestamp":1745251063,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时57分，Mural Oncology Plc股票出现异动，股价大幅下跌5.19%。截至发稿，该股报2.56美元/股，成交量79.95万股，换手率4.64%，振幅6.67%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.22%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":1},{"id":"2528470044","title":"Mural Oncology Plc4月17日成交额为1520.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528470044","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528470044?lang=zh_cn&edition=full","pubTime":"2025-04-18 10:07","pubTimestamp":1744942055,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，Mural Oncology Plc成交额为1520.35万美元，成交额较昨日减少23.23%，当日成交量为576.50万股。Mural Oncology Plc于2025年4月17日涨11.57%，报2.7美元，该股过去5个交易日涨171.36%，年初至今跌16.15%，过去60日跌31.65%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528743925","title":"Mural Oncology Plc盘中异动 早盘股价大涨5.58%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743925?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:41","pubTimestamp":1744897301,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时41分，Mural Oncology Plc股票出现异动，股价大幅拉升5.58%。截至发稿，该股报2.56美元/股，成交量69.6749万股，换手率4.04%，振幅3.30%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.43%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528088787","title":"Mural Oncology Plc4月16日成交额为1980.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528088787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528088787?lang=zh_cn&edition=full","pubTime":"2025-04-17 10:04","pubTimestamp":1744855442,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日，Mural Oncology Plc成交额为1980.46万美元，成交额较昨日减少97.14%，当日成交量为816.28万股。Mural Oncology Plc于2025年4月16日涨0.41%，报2.42美元，该股过去5个交易日涨116.07%，年初至今跌24.84%，过去60日跌41.55%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-16|1980.46万|-97.14%|816.28万|#|2025-04-15|6.93亿|311927.31%|2.60亿|#|2025-04-14|22.20万|-3.03%|21.63万|#|2025-04-11|22.90万|-42.51%|22.43万|#|2025-04-10|39.82万|-42.73%|39.57万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417100411a6bd4a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417100411a6bd4a17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2527407009","title":"Mural Oncology Plc4月15日成交额为6.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527407009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527407009?lang=zh_cn&edition=full","pubTime":"2025-04-16 10:01","pubTimestamp":1744768896,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，Mural Oncology Plc成交额为6.93亿美元，成交额较昨日增加311927.31%，当日成交量为2.60亿股。Mural Oncology Plc于2025年4月15日涨133.98%，报2.41美元，该股过去5个交易日涨121.1%，年初至今跌25.16%，过去60日跌39.75%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-15|6.93亿|311927.31%|2.60亿|#|2025-04-14|22.20万|-3.03%|21.63万|#|2025-04-11|22.90万|-42.51%|22.43万|#|2025-04-10|39.82万|-42.73%|39.57万|#|2025-04-09|69.54万|91.65%|65.49万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100138a45a70fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100138a45a70fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527109417","title":"Mural Oncology Plc盘中异动 早盘大幅拉升127.67%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527109417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527109417?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:31","pubTimestamp":1744723877,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时31分，Mural Oncology Plc股票出现波动，股价快速上涨127.67%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Precision Biosciences, Inc.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为315.32%、195.68%、76.15%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Mural Oncology Plc、Cue Biopharma, Inc.，振幅分别为15.15%、13.59%、12.65%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213117a6bb4abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213117a6bb4abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2517436649","title":"Mural Oncology Plc盘中异动 大幅拉升7.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517436649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517436649?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:48","pubTimestamp":1741186088,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时48分，Mural Oncology Plc股票出现波动，股价快速拉升7.83%。截至发稿，该股报3.70美元/股，成交量1.5802万股，换手率0.09%，振幅3.97%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为1.54%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224808963ae09e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224808963ae09e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2516128663","title":"Mural Oncology Plc盘中异动 快速下挫5.57%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516128663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516128663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:02","pubTimestamp":1741032148,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时02分，Mural Oncology Plc股票出现波动，股价大幅下挫5.57%。截至发稿，该股报3.48美元/股，成交量8.3909万股，换手率0.49%，振幅5.71%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.20%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229989a58d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040229989a58d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2514117100","title":"Mural Oncology Plc盘中异动 临近午盘大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514117100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514117100?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:39","pubTimestamp":1740501599,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时39分，Mural Oncology Plc股票出现波动，股价快速下跌5.18%。截至发稿，该股报3.66美元/股，成交量11.6134万股，换手率0.68%，振幅3.89%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.01%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600395998926735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600395998926735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2513720664","title":"Mural Oncology Plc盘中异动 股价大跌5.19%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720664?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409347,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分，Mural Oncology Plc股票出现波动，股价大幅下挫5.19%。截至发稿，该股报3.84美元/股，成交量4.4995万股，换手率0.26%，振幅7.90%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.24%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230227962ea0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230227962ea0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2510860660","title":"Mural Oncology Plc盘中异动 临近午盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510860660?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:49","pubTimestamp":1739206192,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时49分，Mural Oncology Plc股票出现异动，股价大幅下挫5.59%。截至发稿，该股报4.22美元/股，成交量10.369万股，换手率0.61%，振幅7.38%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.08%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211004952a240bf18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211004952a240bf18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2509628728","title":"Mural Oncology Plc盘中异动 急速上涨6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509628728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509628728?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:33","pubTimestamp":1738942430,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时33分，Mural Oncology Plc股票出现异动，股价快速拉升6.07%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.09%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207233351a23d316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207233351a23d316c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2509820609","title":"Mural Oncology Plc盘中异动 临近午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509820609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509820609?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:31","pubTimestamp":1738859517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时31分，Mural Oncology Plc股票出现异动，股价快速上涨5.14%。截至发稿，该股报4.28美元/股，成交量5.9532万股，换手率0.35%，振幅6.88%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.20%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003157987ca161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003157987ca161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2509233888","title":"Mural Oncology Plc盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509233888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509233888?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:30","pubTimestamp":1738769436,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时30分，Mural Oncology Plc股票出现异动，股价大幅上涨5.15%。截至发稿，该股报3.88美元/股，成交量2.3734万股，换手率0.14%，振幅5.28%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为1.29%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233036987b86fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233036987b86fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.muraloncology.com","stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":1.2478},{"period":"3month","weight":-0.3117},{"period":"6month","weight":-0.2463},{"period":"1year","weight":-0.3368},{"period":"ytd","weight":-0.2112}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mural Oncology plc是一家爱尔兰注册公众有限公司，于2017年5月成立，是一家私人股份有限公司，2023年8月21日，该公司重新注册为公共有限公司，并更名为Mural Oncology plc。该公司是一家临床阶段的肿瘤学公司，专注于发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用公司在免疫细胞调节和蛋白质工程方面的核心竞争力，该公司开发了一系列新型的研究性细胞因子疗法，旨在解决多种癌症患者未满足需求的领域。该公司的主要候选产品nemvaleukin alfa（“nemvaleukin”）是一种研究性、工程化的白细胞介素-2（“IL-2”）细胞因子，旨在捕获和扩大大剂量重组人IL-2（“rhIL-2”）的治疗益处，同时减轻其标志性毒性。","exchange":"NASDAQ","name":"Mural Oncology","nameEN":"Mural Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mural Oncology,MURA,Mural Oncology股票,Mural Oncology股票老虎,Mural Oncology股票老虎国际,Mural Oncology行情,Mural Oncology股票行情,Mural Oncology股价,Mural Oncology股市,Mural Oncology股票价格,Mural Oncology股票交易,Mural Oncology股票购买,Mural Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}